ArticleUltrasonics sonochemistry2026
Ultrasound-assisted deep eutectic solvent extraction of polysaccharides from Melastoma dodecandrum: RSM optimization, ANN prediction, kinetics, structural characterization and cellular antioxidant activity.
Article in Ultrasonics sonochemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Natural polysaccharides have attracted much attention due to their biocompatibility, biodegradability, low toxicity and various biological activities. However, the extraction of polysaccharides from Melastoma dodecandrum Lour. (MD) in a sustainable and effective way remains a challenge. In the present study ultrasound-assisted deep eutectic solvent (UA-DES) extraction strategy was developed to improve the yield and bioactivity of MD polysaccharides (MDPs). Among the twenty-five prepared DES systems, DES-3.2 (choline chloride:citric acid, 1:2) showed the best extraction performance. Response surface methodology (RSM) was applied for optimization of the extraction parameters and artificial neural network (ANN) model was established to predict the extraction behavior and performance. In addition, extraction kinetics was successfully described by second-order kinetic model. Under the optimized conditions of liquid-solid ratio of 30 mL/g, ultrasonic temperature of 60 °C, ultrasonic power of 360 W and ultrasonic time of 90 min, the MDPs yield reached 1.38 %, which was increased by 51.65 % compared with conventional HWE. Furthermore, ANN outperformed RSM in prediction accuracy and effectively captured the complex nonlinear interactions inherent to the extraction process. Structural characterization (SEM, FT-IR, XRD, HPGPC and TGA) analysis revealed that UA-DES extraction caused significant disruption of plant cell walls without changing the characteristic functional groups and amorphous structure of MDPs accompanied by higher molecular weight and thermal stability. Monosaccharide composition analysis identified galactose, galacturonic acid, and glucose as the predominant components with UA-DES extraction significantly enrich the galacturonic acid content compared with HWE. Further, UA-DES extracted MDPs had stronger antioxidant capacity in chemical assays and exerted higher antioxidant and anti-inflammatory effects in cells by significantly decreasing intracellular reactive oxygen species (ROS) and nitric oxide (NO) levels in LPS induced RAW264.7 macrophages without cytotoxicity. Additionally, DES-3.2 maintained over 91.25 % recovery after five recycling cycles, with only a 5.78 % loss in extraction efficiency of MDPs. Despite the modest absolute yield of 1.38 %, the excellent recyclability of DES-3.2 provides a strong economic counterbalance by reducing solvent costs and waste generation. Overall, UA-DES extraction is an effective, green, high-performance approach for extracting structurally distinct and bioactive MDPs for applications in functional foods, nutraceuticals and pharmaceuticals.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.